2022
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study
Gregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study. European Journal Of Nuclear Medicine And Molecular Imaging 2022, 50: 921-928. PMID: 36282299, DOI: 10.1007/s00259-022-06002-5.Peer-Reviewed Original ResearchConceptsSelective internal radiation therapyTextbook outcomeInternal radiation therapyHepatocellular carcinomaRadiation therapyPatient-important outcomesLarge observational studiesNuclear medicine physiciansEntire intervention processRandomized trialsRoutine careResultsA totalObservational studyMultistep interventionMedicine physiciansInterventional radiologistsSenior authorClinical roundsCarcinomaTherapyInterventionOutcomes
2021
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
Levillain H, Bagni O, Deroose CM, Dieudonné A, Gnesin S, Grosser OS, Kappadath SC, Kennedy A, Kokabi N, Liu DM, Madoff DC, Mahvash A, Martinez de la Cuesta A, Ng DCE, Paprottka PM, Pettinato C, Rodríguez-Fraile M, Salem R, Sangro B, Strigari L, Sze DY, de Wit van der veen BJ, Flamen P. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. European Journal Of Nuclear Medicine And Molecular Imaging 2021, 48: 1570-1584. PMID: 33433699, PMCID: PMC8113219, DOI: 10.1007/s00259-020-05163-5.Peer-Reviewed Original ResearchConceptsSelective internal radiation therapyInternal radiation therapyActivity prescriptionRadiation therapyLiver metastatic colorectal cancerYttrium-90 resin microspheresResin microspheresMetastatic liver diseaseMetastatic colorectal cancerMultidisciplinary expert panelNon-tumoural liverSPECT/CTLiver diseaseColorectal cancerTreatment strategiesHepatocellular carcinomaSteering CommitteePost-treatment dosimetryYttrium-90Multidisciplinary teamTherapeutic intentMicrosphere activityWhole liverLiterature searchLevel of agreement
2013
Educational Exhibit Abstract No. 393 Future improvements in the role of PET-CT in the assessment of hepatocellular carcinoma, prior to and following the selective internal radiation therapy (SIRT) of Yttrium-90 (Y-90)
Chheang S, Tarlington L, Osborne J, Deh K, Madoff D. Educational Exhibit Abstract No. 393 Future improvements in the role of PET-CT in the assessment of hepatocellular carcinoma, prior to and following the selective internal radiation therapy (SIRT) of Yttrium-90 (Y-90). Journal Of Vascular And Interventional Radiology 2013, 24: s167. DOI: 10.1016/j.jvir.2013.01.422.Peer-Reviewed Original ResearchSelective internal radiation therapyHepatocellular carcinomaNovel PET tracersPET-CTFDG-PETMaximum standardized uptake valuePET tracersNonresectable hepatocellular carcinomaFDG PET-CTStandardized uptake valueInternal radiation therapyPost-treatment evaluationPET-CT imagingY90 radioembolizationConcurrent inflammationResidual tumorMultiple neoplasmsPotential adjunctTreatment outcomesTreatment responseRadiation therapyGI tractNew agentsUptake valueYttrium-90